LEADER 04056nam  22006254a 450 
001 9910457986703321
005 20200520144314.0
010   $a1-280-48176-5
010   $a9786610481767
010   $a1-4237-4580-9
010   $a0-19-974902-7
010   $a1-4337-0112-X
035   $a(CKB)1000000000363071
035   $a(SSID)ssj0000123625
035   $a(PQKBManifestationID)11143780
035   $a(PQKBTitleCode)TC0000123625
035   $a(PQKBWorkID)10010242
035   $a(PQKB)11618692
035   $a(MiAaPQ)EBC3052073
035   $a(MiAaPQ)EBC279845
035   $a(Au-PeEL)EBL3052073
035   $a(CaPaEBR)ebr10142387
035   $a(CaONFJC)MIL48176
035   $a(OCoLC)62892806
035   $a(Au-PeEL)EBL279845
035   $a(OCoLC)935262160
035   $a(EXLCZ)991000000000363071
100   $a20021211d2003      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aClinical mycology$b[electronic resource] /$fedited by William E. Dismukes, Peter G. Pappas, Jack D. Sobel
210   $aOxford ;$aNew York $cOxford University Press$d2003
215   $axiii, 519 p., [24] p. of plates $cill. (some col.)
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-19-514809-6 
320   $aIncludes bibliographical references and index.
327   $aIntro -- Contents -- Contributors -- PART I: INTRODUCTION -- 1. Laboratory Aspects of Medical Mycology -- 2. Epidemiology of Systemic Fungal Diseases: Overview -- PART II: SYSTEMIC ANTIFUNGAL DRUGS -- 3. Amphotericin B -- 4. Liposomal Nystatin -- 5. Flucytosine -- 6. Azole Antifungal Drugs -- 7. Cell Wall Synthesis Inhibitors: Echinocandins and Nikkomycins -- 8. Terbinafine -- 9. Resistance to Antifungal Drugs -- 10. Adjunctive Antifungal Therapy -- PART III:  MYCOSES CAUSED BY YEASTS -- 11. Candidiasis -- 12. Cryptococcosis -- 13. Rhodotorula, Malassezia, Trichosporon, and Other Yeast-Like Fungi -- PART IV:  MYCOSES CAUSED BY MOULDS -- 14. Aspergillosis -- 15. Zygomycoses -- 16. Hyalohyphomycoses (other than Aspergillosis and Penicilliosis) -- 17. Phaeohyphomycoses -- PART V:  MYCOSES CAUSED BY DIMORPHIC FUNGI -- 18. Histoplasmosis -- 19. Blastomycosis -- 20. Coccidioidomycosis -- 21. Paracoccidioidomycosis -- 22. Sporotrichosis -- 23. Penicilliosis -- PART VI:  MYCOLOGY INVOLVING SKIN AND SUBCUTANEOUS TISSUES -- 24. Superficial Cutaneous Fungal Infections -- 25. Eumycetoma -- 26. Chromoblastomycosis -- PART VII:  OTHER MYCOSES -- 27. Pneumocystosis -- 28. Miscellaneous Fungi -- PART VIII:  SPECIAL PATIENT POPULATIONS -- 29. Fungal Infections in Neutropenic Patients -- 30. Fungal Infections in Blood or Marrow Transplant Recipients -- 31. Fungal Infections in Solid Organ Transplant Recipients -- 32. Fungal Infections among Patients with AIDS -- Index.
330   $aWithin the field of infectious diseases, medical mycology has experienced significant growth over the last decade. Invasive fungal infections have been increasing in many patient populations, including: those with AIDS; transplant recipients; and the elderly. As these populations grow, so does the diversity of fungal pathogens. Paralleling this development, there have been recent launches of several new antifungal drugs and therapies. Clinical Mycology offers a comprehensive review of this discipline. Organized by types of fungi, this volume covers microbiologic, epidemiologic and demographic aspects of fungal infections as well as diagnostic, clinical, therapeutic, and preventive approaches. Special patient populations are also detailed.
606   $aMedical mycology
608   $aElectronic books.
615  0$aMedical mycology.
676   $a616/.015
701   $aDismukes$b William E$01056321
701   $aPappas$b Peter G$01056322
701   $aSobel$b Jack D$01056323
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910457986703321
996   $aClinical mycology$92490612
997   $aUNINA